http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Zomedica Initiates ZM-006 Pilot Efficacy Study and Provides Corporate Updates
-
Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results
-
Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs
-
Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update
-
Zomedica Provides Update on Pipeline Development and Announces At-The-Market Offering Program
-
Zomedica Pharmaceuticals (ZOM) Reports $10 Million Private Offering of Common Shares
-
Zomedica Announces $10 Million Private Offering of Common Shares
-
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results
-
Zomedica Pharmaceuticals Corp. to Present at Jefferies 2018 London Healthcare Conference and LD Micro Main Event XI
-
Zomedica Pharmaceuticals Corp. to Present at LD Micro NYC Summit and Cantor 2018 Global Healthcare Conference
-
Zomedica Announces 2018 Annual Meeting Results
-
Zomedica Pharmaceuticals Corp. Announces Second Quarter 2018 Financial Results
-
Zomedica Announces Interim Closing and Extension of Its Private Offering of Common Shares
-
Zomedica Joins Russell 3000™ and Russell Microcap® Indexes
-
Zomedica Provides Product Development Update
-
Zomedica Announces Changes to Commercialization Leadership Team
-
Zomedica Pharmaceuticals Corp. Announces First Quarter 2018 Financial Results
-
Zomedica Pharmaceuticals (ZOM) Prices 4.65M Share Private Offering at $2.15/Sh
-
Zomedica Announces Up to $10 Million Private Offering of Common Shares
-
Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic
-
Zomedica to Present at 2018 Disruptive Growth & Healthcare Conference
-
Zomedica to Present at 30th Annual ROTH Conference
-
Zomedica Pharmaceuticals Corp. Announces Year End 2017 Financial Results
-
Zomedica to Participate in the Bank of America Merrill Lynch Animal Health Summit
-
Zomedica Pharmaceuticals (ZOM) Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform
-
Zomedica Pharmaceuticals Corp. Enters into License and Supply Agreement with Celsee, Inc. for Cancer Liquid Biopsy Platform
-
Zomedica Pharmaceuticals (ZOM) Announces Development Update
-
Zomedica Announces Achievement of Therapeutic Development Milestones
-
Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission
-
Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017
-
Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval
-
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results
-
Zomedica Pharmaceuticals Corp. to Present at Jefferies 2017 London Healthcare Conference and LD Micro Main Event 2017
-
Zomedica Pharmaceuticals Corp. Announces US$5M Unsecured Working Capital Loan Facility

